Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Chicago Atlantic Real Estate Finance (NASDAQ:REFI): Can This Cannabis Lender Turn the Story Around?

Chicago Atlantic Real Estate Finance (NASDAQ:REFI) is a commercialMortgagereal estateInvestmenttrust that specializes in lending to companies in the cannabis industry, a niche where conventional bank financing is scarce and yields on senior secured loans tend to run higher. Shares closed at $10.86 at last …

Nitish Kishor | 04 September 2026

Signet Jewelers (NYSE:SIG): Is the Pullback Finally Over?

Signet Jewelers (NYSE:SIG) is the world's largest retailer of diamond jewelry, operating well-known banners such as Kay Jewelers, Zales, Jared, and others across the United States and internationally, along with online operations. Shares closed at $82.02 at last closing, up 0.35%.

Nitish Kishor | 04 September 2026

Silgan Holdings (NYSE:SLGN): Packaging Demand Remains the Story to Watch

Silgan Holdings (NYSE:SLGN) is a leading manufacturer of rigid packaging for consumer goods, operating three segments: dispensing and specialty closures, metal containers, and custom containers. Shares closed at $41.51 at last closing, up 0.44%.

Nitish Kishor | 04 September 2026

Oculis Holding (NASDAQ:OCS): Neuro-Ophthalmology Pipeline Still the Catalyst to Watch

Oculis Holding (NASDAQ:OCS) is a clinical-stage biopharmaceutical company focused on developing treatments for ophthalmic and related diseases, with a pipeline that includes candidates for conditions such as diabetic macular edema, dry-eye disease, and, notably, acute optic neuritis, a neuro-ophthalmic condition. Shares closed at $12.17 …

Nitish Kishor | 04 September 2026

Penny Stock OKYO Pharma (NASDAQ:OKYO) Falls to $1.55: What Would It Take to Revive the Stock?

Penny stock OKYO Pharma (NASDAQ:OKYO) is a clinical-stage biopharmaceutical company developing therapies for ophthalmic and inflammatory diseases, with its lead candidate, urcosimod, being studied for neuropathic corneal pain, a serious and underserved eye condition, and for dry-eye disease. Shares closed at $1.55 at last …

Nitish Kishor | 04 September 2026

This Clinical-Stage Oncology Stock Has Gone Quiet: Is a Surprise Move Coming?

This clinical-stage oncology penny stock, PMV Pharmaceuticals (NASDAQ:PMVP), is developing cancer therapies that target the p53 tumor-suppressor pathway, one of the most commonly mutated pathways in cancer. Shares closed at $1.24 at last closing, down 1.59%.

Nitish Kishor | 04 September 2026

Ultragenyx Pharmaceutical (NASDAQ:RARE) Plunges 44% as Phase 3 Angelman Syndrome Trial Fails to Meet Endpoints

Ultragenyx Pharmaceutical (NASDAQ:RARE) shares closed at $14.85 at last closing, down 44.03%, after the company announced that its Phase 3 Aspire study of apazunersen (GTX-102) in Angelman syndrome did not achieve its primary endpoint of change from baseline in Bayley-4 cognitive raw score, nor …

Nitish Kishor | 04 September 2026

Penny Stock Marti Technologies (NYSE American:MRT) Rallies: Turkey Ride-Hailing Growth Remains the Focus

Penny stock Marti Technologies (NYSE American:MRT) is a mobility company operating in Turkey, providing a ride-hailing marketplace connecting riders with drivers, along with shared electric mopeds, motorcycles, e-bikes and scooters. Shares closed at $2.27 at last closing, up 4.61%.

Nitish Kishor | 04 September 2026

Penny Stock indie Semiconductor (NASDAQ:INDI) Slips as Wave of Insider Selling Weighs on Sentiment

Penny stock indie Semiconductor (NASDAQ:INDI) is a fabless semiconductor company focused on the automotive market, developing chips and software for advanced driver-assistance systems, in-cabin sensing, connectivity, and vehicle electrification. Shares closed at $3.47 at last closing, down 2.80%, as a steady drumbeat of executive …

Nitish Kishor | 04 September 2026

Penny Stock Intelligent Protection Management (NASDAQ:IPM) Jumps: Is a Cybersecurity Turnaround Underway?

Penny stock Intelligent Protection Management (NASDAQ:IPM) is a managed-technology-solutions provider focused onCybersecurityand cloud infrastructure, offering dedicated and cloud hosting, data storage, managed security, backup and disaster-recovery services, and consulting for enterprise and commercial clients. Shares closed at $1.92 at last closing, up 4.92%.

Nitish Kishor | 04 September 2026
Support

Hi! How can we help you today?

Loading…